Ten‐Eleven Translocation 1 Promotes Malignant Progression of Cholangiocarcinoma With Wild‐Type Isocitrate Dehydrogenase 1-Reference-Cited by-同舟云学术

Ten‐Eleven Translocation 1 Promotes Malignant Progression of Cholangiocarcinoma With Wild‐Type Isocitrate Dehydrogenase 1

Published:2021-04-29 Issue:5 Volume:73 Page:1747-1763
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Bai Xuewei¹²,Zhang Hongyu²,Zhou Yamei¹²,Nagaoka Katsuya²,Meng Jialin³⁴,Ji Chengcheng²,Liu Dan²,Dong Xianghui⁵,Cao Kevin²,Mulla Joud²,Cheng Zhixiang²,Mueller William²,Bay Amalia²,Hildebrand Grace²,Lu Shaolei⁶,Wallace Joselynn⁷,Wands Jack R.²,Sun Bei¹,Huang Chiung‐Kuei²

Affiliation:

1. Department of Pancreatic and Biliary Surgery First Affiliated Hospital of Harbin Medical University Harbin China

2. Liver Research Center Division of Gastroenterology & Liver Research Center Warren Alpert Medical School of Brown University and Rhode Island Hospital Providence RI

3. Department of Urology The First Affiliated Hospital of Anhui Medical University Hefei China

4. Institute of Urology & Anhui Province Key Laboratory of Genitourinary Diseases Anhui Medical University Hefei China

5. Department of Pathology The First Affiliated Hospital of Harbin Medical University Harbin P.R. China

6. Department of Pathology and Laboratory Medicine Warren Alpert Medical School of Brown UniversityRhode Island Hospital Providence RI

7. Center for Computational Biology of Human Disease and Center for Computation and Visualization Brown University Providence RI

Funder

Rhode Island Foundation

National Institute of General Medical Sciences

American Association for the Study of Liver Diseases

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hep.31486

Reference42 articles.

1. Cholangiocarcinoma

2. Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas

3. Exome sequencing identifies distinct mutational patterns in liver fluke–related and non-infection-related bile duct cancers

4. Mutant IDH inhibits HNF-4α to block hepatocyte differentiation and promote biliary cancer

5. Cancer-associated IDH1 mutations produce 2-hydroxyglutarate

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prenatal 1‐Nitropyrene Exposure Causes Autism‐Like Behavior Partially by Altering DNA Hydroxymethylation in Developing Brain;Advanced Science;2024-05-16

2. Gestational α-ketoglutarate supplementation ameliorates arsenic-induced hepatic lipid deposition via epigenetic reprogramming of β-oxidation process in female offspring;Environment International;2024-03

3. Epigenetic regulation in cancer therapy: From mechanisms to clinical advances;MedComm – Oncology;2024-01-04

4. Elevated 2-oxoglutarate antagonizes DNA damage responses in cholangiocarcinoma chemotherapy through regulating aspartate beta-hydroxylase;Cancer Letters;2024-01

5. Progress in the research of epigenetic regulators in cancer therapy;SCIENTIA SINICA Vitae;2023-11-01